TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Endocrine Testing Market
Global Endocrine Testing Market Research Report 2023

Global Endocrine Testing Market Research Report 2023

  • Category:Life Sciences
  • Published on : 14 February 2023
  • Pages :116
  • Formats:
  • Report Code:SMR-7565769

Market Analysis and Insights: Global Endocrine Testing Market

The global Endocrine Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocrine Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocrine Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocrine Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocrine Testing market.

Global Endocrine Testing Scope and Market Size

Endocrine Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Endocrine Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.
Segment by Type
Tandem Mass Spectrometry
Immunoassay
Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Endocrine Testing product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Endocrine Testing, with price, sales, revenue, and global market share of Endocrine Testing from 2019 to 2022.

Chapter 3, the Endocrine Testing competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Endocrine Testing breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Endocrine Testing market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Endocrine Testing.

Chapter 13, 14, and 15, to describe Endocrine Testing sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Endocrine Testing Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Tandem Mass Spectrometry
1.2.3 Immunoassay
1.3 Market by Application
1.3.1 Global Endocrine Testing Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2018-2032)
2.2 Endocrine Testing Growth Trends by Region
2.2.1 Endocrine Testing Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Endocrine Testing Historic Market Size by Region (2018-2023)
2.2.3 Endocrine Testing Forecasted Market Size by Region (2023-2032)
2.3 Endocrine Testing Market Dynamics
2.3.1 Endocrine Testing Industry Trends
2.3.2 Endocrine Testing Market Drivers
2.3.3 Endocrine Testing Market Challenges
2.3.4 Endocrine Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Testing Players by Revenue
3.1.1 Global Top Endocrine Testing Players by Revenue (2018-2023)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2018-2023)
3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocrine Testing Revenue
3.4 Global Endocrine Testing Market Concentration Ratio
3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2022
3.5 Endocrine Testing Key Players Head office and Area Served
3.6 Key Players Endocrine Testing Product Solution and Service
3.7 Date of Enter into Endocrine Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Testing Breakdown Data by Type
4.1 Global Endocrine Testing Historic Market Size by Type (2018-2023)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2023-2032)
5 Endocrine Testing Breakdown Data by Application
5.1 Global Endocrine Testing Historic Market Size by Application (2018-2023)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Endocrine Testing Market Size (2018-2032)
6.2 North America Endocrine Testing Market Size by Country (2018-2023)
6.3 North America Endocrine Testing Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endocrine Testing Market Size (2018-2032)
7.2 Europe Endocrine Testing Market Size by Country (2018-2023)
7.3 Europe Endocrine Testing Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Testing Market Size (2018-2032)
8.2 Asia-Pacific Endocrine Testing Market Size by Country (2018-2023)
8.3 Asia-Pacific Endocrine Testing Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endocrine Testing Market Size (2018-2032)
9.2 Latin America Endocrine Testing Market Size by Country (2018-2023)
9.3 Latin America Endocrine Testing Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Testing Market Size (2018-2032)
10.2 Middle East & Africa Endocrine Testing Market Size by Country (2018-2023)
10.3 Middle East & Africa Endocrine Testing Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrine Testing Introduction
11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AdnaGen
11.2.1 AdnaGen Company Detail
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Endocrine Testing Introduction
11.2.4 AdnaGen Revenue in Endocrine Testing Business (2018-2023)
11.2.5 AdnaGen Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Detail
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2018-2023)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Detail
11.4.2 Biomedical Diagnostics Business Overview
11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2018-2023)
11.4.5 Biomedical Diagnostics Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Endocrine Testing Introduction
11.5.4 BioMerieux Revenue in Endocrine Testing Business (2018-2023)
11.5.5 BioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Endocrine Testing Introduction
11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2018-2023)
11.6.5 Bio-Rad Recent Development
11.7 Dako
11.7.1 Dako Company Detail
11.7.2 Dako Business Overview
11.7.3 Dako Endocrine Testing Introduction
11.7.4 Dako Revenue in Endocrine Testing Business (2018-2023)
11.7.5 Dako Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Endocrine Testing Introduction
11.8.4 DiaSorin Revenue in Endocrine Testing Business (2018-2023)
11.8.5 DiaSorin Recent Development
11.9 Eiken
11.9.1 Eiken Company Detail
11.9.2 Eiken Business Overview
11.9.3 Eiken Endocrine Testing Introduction
11.9.4 Eiken Revenue in Endocrine Testing Business (2018-2023)
11.9.5 Eiken Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Detail
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Endocrine Testing Introduction
11.10.4 Fujirebio Revenue in Endocrine Testing Business (2018-2023)
11.10.5 Fujirebio Recent Development
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Detail
11.11.2 Instrumentation Laboratory Business Overview
11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2018-2023)
11.11.5 Instrumentation Laboratory Recent Development
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Detail
11.12.2 Kyowa Medex Business Overview
11.12.3 Kyowa Medex Endocrine Testing Introduction
11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2018-2023)
11.12.5 Kyowa Medex Recent Development
11.13 Matritech
11.13.1 Matritech Company Detail
11.13.2 Matritech Business Overview
11.13.3 Matritech Endocrine Testing Introduction
11.13.4 Matritech Revenue in Endocrine Testing Business (2018-2023)
11.13.5 Matritech Recent Development
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Detail
11.14.2 Ortho-Clinical Diagnostics Business Overview
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2018-2023)
11.14.5 Ortho-Clinical Diagnostics Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Endocrine Testing Introduction
11.15.4 Roche Revenue in Endocrine Testing Business (2018-2023)
11.15.5 Roche Recent Development
11.16 Siemens
11.16.1 Siemens Company Detail
11.16.2 Siemens Business Overview
11.16.3 Siemens Endocrine Testing Introduction
11.16.4 Siemens Revenue in Endocrine Testing Business (2018-2023)
11.16.5 Siemens Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Detail
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Endocrine Testing Introduction
11.17.4 Sysmex Revenue in Endocrine Testing Business (2018-2023)
11.17.5 Sysmex Recent Development
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Detail
11.18.2 Thermo Fisher Business Overview
11.18.3 Thermo Fisher Endocrine Testing Introduction
11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2018-2023)
11.18.5 Thermo Fisher Recent Development
11.19 Tosoh
11.19.1 Tosoh Company Detail
11.19.2 Tosoh Business Overview
11.19.3 Tosoh Endocrine Testing Introduction
11.19.4 Tosoh Revenue in Endocrine Testing Business (2018-2023)
11.19.5 Tosoh Recent Development
11.20 Wako
11.20.1 Wako Company Detail
11.20.2 Wako Business Overview
11.20.3 Wako Endocrine Testing Introduction
11.20.4 Wako Revenue in Endocrine Testing Business (2018-2023)
11.20.5 Wako Recent Development
11.21 Wallac/PE
11.21.1 Wallac/PE Company Detail
11.21.2 Wallac/PE Business Overview
11.21.3 Wallac/PE Endocrine Testing Introduction
11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2018-2023)
11.21.5 Wallac/PE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Tandem Mass Spectrometry
Table 3. Key Players of Immunoassay
Table 4. Global Endocrine Testing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 5. Global Endocrine Testing Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Endocrine Testing Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Endocrine Testing Market Share by Region (2018-2023)
Table 8. Global Endocrine Testing Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 9. Global Endocrine Testing Market Share by Region (2023-2032)
Table 10. Endocrine Testing Market Trends
Table 11. Endocrine Testing Market Drivers
Table 12. Endocrine Testing Market Challenges
Table 13. Endocrine Testing Market Restraints
Table 14. Global Endocrine Testing Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Endocrine Testing Market Share by Players (2018-2023)
Table 16. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2022)
Table 17. Ranking of Global Top Endocrine Testing Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Endocrine Testing Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endocrine Testing Product Solution and Service
Table 21. Date of Enter into Endocrine Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Testing Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Endocrine Testing Revenue Market Share by Type (2018-2023)
Table 25. Global Endocrine Testing Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 26. Global Endocrine Testing Revenue Market Share by Type (2023-2032)
Table 27. Global Endocrine Testing Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Endocrine Testing Revenue Market Share by Application (2018-2023)
Table 29. Global Endocrine Testing Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 30. Global Endocrine Testing Revenue Market Share by Application (2023-2032)
Table 31. North America Endocrine Testing Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Endocrine Testing Market Size by Country (2023-2032) & (US$ Million)
Table 33. Europe Endocrine Testing Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Endocrine Testing Market Size by Country (2023-2032) & (US$ Million)
Table 35. Asia-Pacific Endocrine Testing Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Endocrine Testing Market Size by Region (2023-2032) & (US$ Million)
Table 37. Latin America Endocrine Testing Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Endocrine Testing Market Size by Country (2023-2032) & (US$ Million)
Table 39. Middle East & Africa Endocrine Testing Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Endocrine Testing Market Size by Country (2023-2032) & (US$ Million)
Table 41. Abbott Laboratories Company Detail
Table 42. Abbott Laboratories Business Overview
Table 43. Abbott Laboratories Endocrine Testing Product
Table 44. Abbott Laboratories Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 45. Abbott Laboratories Recent Development
Table 46. AdnaGen Company Detail
Table 47. AdnaGen Business Overview
Table 48. AdnaGen Endocrine Testing Product
Table 49. AdnaGen Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 50. AdnaGen Recent Development
Table 51. Beckman Coulter/Danaher Company Detail
Table 52. Beckman Coulter/Danaher Business Overview
Table 53. Beckman Coulter/Danaher Endocrine Testing Product
Table 54. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 55. Beckman Coulter/Danaher Recent Development
Table 56. Biomedical Diagnostics Company Detail
Table 57. Biomedical Diagnostics Business Overview
Table 58. Biomedical Diagnostics Endocrine Testing Product
Table 59. Biomedical Diagnostics Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 60. Biomedical Diagnostics Recent Development
Table 61. BioMerieux Company Detail
Table 62. BioMerieux Business Overview
Table 63. BioMerieux Endocrine Testing Product
Table 64. BioMerieux Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 65. BioMerieux Recent Development
Table 66. Bio-Rad Company Detail
Table 67. Bio-Rad Business Overview
Table 68. Bio-Rad Endocrine Testing Product
Table 69. Bio-Rad Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 70. Bio-Rad Recent Development
Table 71. Dako Company Detail
Table 72. Dako Business Overview
Table 73. Dako Endocrine Testing Product
Table 74. Dako Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 75. Dako Recent Development
Table 76. DiaSorin Company Detail
Table 77. DiaSorin Business Overview
Table 78. DiaSorin Endocrine Testing Product
Table 79. DiaSorin Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 80. DiaSorin Recent Development
Table 81. Eiken Company Detail
Table 82. Eiken Business Overview
Table 83. Eiken Endocrine Testing Product
Table 84. Eiken Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 85. Eiken Recent Development
Table 86. Fujirebio Company Detail
Table 87. Fujirebio Business Overview
Table 88. Fujirebio Endocrine Testing Product
Table 89. Fujirebio Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 90. Fujirebio Recent Development
Table 91. Instrumentation Laboratory Company Detail
Table 92. Instrumentation Laboratory Business Overview
Table 93. Instrumentation Laboratory Endocrine TestingProduct
Table 94. Instrumentation Laboratory Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 95. Instrumentation Laboratory Recent Development
Table 96. Kyowa Medex Company Detail
Table 97. Kyowa Medex Business Overview
Table 98. Kyowa Medex Endocrine TestingProduct
Table 99. Kyowa Medex Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 100. Kyowa Medex Recent Development
Table 101. Matritech Company Detail
Table 102. Matritech Business Overview
Table 103. Matritech Endocrine TestingProduct
Table 104. Matritech Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 105. Matritech Recent Development
Table 106. Ortho-Clinical Diagnostics Company Detail
Table 107. Ortho-Clinical Diagnostics Business Overview
Table 108. Ortho-Clinical Diagnostics Endocrine TestingProduct
Table 109. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 110. Ortho-Clinical Diagnostics Recent Development
Table 111. Roche Company Detail
Table 112. Roche Business Overview
Table 113. Roche Endocrine TestingProduct
Table 114. Roche Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 115. Roche Recent Development
Table 116. Siemens Company Detail
Table 117. Siemens Business Overview
Table 118. Siemens Endocrine TestingProduct
Table 119. Siemens Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 120. Siemens Recent Development
Table 121. Sysmex Company Detail
Table 122. Sysmex Business Overview
Table 123. Sysmex Endocrine TestingProduct
Table 124. Sysmex Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 125. Sysmex Recent Development
Table 126. Thermo Fisher Company Detail
Table 127. Thermo Fisher Business Overview
Table 128. Thermo Fisher Endocrine TestingProduct
Table 129. Thermo Fisher Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 130. Thermo Fisher Recent Development
Table 131. Tosoh Company Detail
Table 132. Tosoh Business Overview
Table 133. Tosoh Endocrine TestingProduct
Table 134. Tosoh Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 135. Tosoh Recent Development
Table 136. Wako Company Detail
Table 137. Wako Business Overview
Table 138. Wako Endocrine TestingProduct
Table 139. Wako Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 140. Wako Recent Development
Table 141. Wallac/PE Company Detail
Table 142. Wallac/PE Business Overview
Table 143. Wallac/PE Endocrine TestingProduct
Table 144. Wallac/PE Revenue in Endocrine Testing Business (2018-2023) & (US$ Million)
Table 145. Wallac/PE Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Testing Market Share by Type: 2022 VS 2032
Figure 2. Tandem Mass Spectrometry Features
Figure 3. Immunoassay Features
Figure 4. Global Endocrine Testing Market Share by Application in 2022 & 2032
Figure 5. Hospitals Case Studies
Figure 6. Commercial Laboratories Case Studies
Figure 7. Ambulatory Care Centres Case Studies
Figure 8. Other Setting Case Studies
Figure 9. Endocrine Testing Report Years Considered
Figure 10. Global Endocrine Testing Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 11. Global Endocrine Testing Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 12. Global Endocrine Testing Market Share by Region: 2022 VS 2032
Figure 13. Global Endocrine Testing Market Share by Players in 2022
Figure 14. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2022
Figure 16. North America Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 17. North America Endocrine Testing Market Share by Country (2018-2032)
Figure 18. United States Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Canada Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 21. Europe Endocrine Testing Market Share by Country (2018-2032)
Figure 22. Germany Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. France Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. U.K. Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Italy Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Russia Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Nordic Countries Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Asia-Pacific Endocrine Testing Market Share by Region (2018-2032)
Figure 30. China Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Japan Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. South Korea Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. Southeast Asia Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. India Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Australia Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. Latin America Endocrine Testing Market Share by Country (2018-2032)
Figure 38. Mexico Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Brazil Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 41. Middle East & Africa Endocrine Testing Market Share by Country (2018-2032)
Figure 42. Turkey Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Saudi Arabia Endocrine Testing Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Abbott Laboratories Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 45. AdnaGen Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 46. Beckman Coulter/Danaher Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 47. Biomedical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 48. BioMerieux Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 49. Bio-Rad Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 50. Dako Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 51. DiaSorin Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 52. Eiken Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 53. Fujirebio Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 54. Instrumentation Laboratory Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 55. Kyowa Medex Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 56. Matritech Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 57. Ortho-Clinical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 58. Roche Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 59. Siemens Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 60. Sysmex Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 61. Thermo Fisher Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 62. Tosoh Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 63. Wako Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 64. Wallac/PE Revenue Growth Rate in Endocrine Testing Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Download
Free Sample
Request
Customization
Check
Discount

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount